Table 4.
Anti-virus activity of apigenin
| Virus | Mechanism of action | Dose/concentration | References |
|---|---|---|---|
| EBV | Inhibits expression of EBV lytic proteins, Zta, Rta, EAD, and DNase | 200 to 295 μM (24 h); 69 to 158 μM (48 h) | An et al. [56] |
| African swine fever virus | Inhibits ASFV-specific protein synthesis and viral factory formation | IC50:212.1 ± 11.5 μM | Hakobyan et al. [57] |
| HCV | Inhibits HCV replication by decreasing mature miR122 expression | 5 μM | Shibata et al. [58] |
| SARS-CoV 3CLpro | Inhibits SARS-CoV 3CLpro | 280.8 μM | Ryu et al. [59] |
| PEDV | Interferes PEDV replication | Choi et al. [60] | |
| FMD virus | Inhibits cytopathogenic effect and FMDV replication | Qian et al. [61] | |
| HIV | Inhibits CYP3A4, slowdown elimination of PIs | Kehinde et al. [62] | |
| Influenza virus | 1.43 μg/mL | Liu et al. [51] | |
| Vaccinia virus | Inhibits VV replication | Chang et al. [63] | |
| PV-2 | 12.2–13.3 μM | Visintini Jaime et al. [64] |